BIOLOGICAL · Unmapped registry intervention
HIV p24/MF59 Vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Test the Safety of Three Experimental HIV Vaccines
NCT00000946
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
ALVAC-HIV MN120TMG (vCP205)
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
ALVAC-RG Rabies Glycoprotein (vCP65)
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
rgp120/HIV-1 SF-2
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Test the Safety of Three Experimental HIV Vaccines
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
HIV Seronegativityunresolved
Interventions
HIV p24/MF59 VaccineBIOLOGICAL
ALVAC-HIV MN120TMG (vCP205)BIOLOGICAL
ALVAC-RG Rabies Glycoprotein (vCP65)BIOLOGICAL
rgp120/HIV-1 SF-2BIOLOGICAL
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00000946 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.